WALGREEN COMPANY for WALGREEN COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| HEATHER HERNDON SMITH | — |
Financial Institutions/Investments/Securities FIN
S. 575- the "Debit Interchange Fee Study Act of 2011"- all provisions regarding studying the market and appropriate regulatory structure for electronic debit card transactions. HR. 1081- the "Consumers Payment System Protection Act" -all provisions regarding delaying the implementation of proposed or final rules issued under the authority of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the reasonable and proportional fees and rules for electronic debit transactions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| HEATHER HERNDON SMITH | — |
Health Issues HCR
HR. 2- the "Repealing the Job Killing Health Care Law Act"- any discussions or provisions repealing Average Manufacturer's Price (AMP) and medication therapy management (MTM). H. Res. 9- the "Replace" bill- all provisions regarding the instruction of certain committees to report legislation replacing the job-killing health law, specifically with regards to discussions of Average Manufacturer's Price (AMP) and medication therapy management (MTM). HR. 5-the "Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2011"-all provisions regarding capping damages at the greater of $250,000 or double the award of economic damages for certain health providers. S. 312/HR.605-the "Patient Freedom to Choose Act"-all provisions regarding repealing provisions of the Patient Protection and Affordable Care Act that restrict payments from health flexible spending arrangements for medications to prescription drugs and insulin.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| HEATHER HERNDON SMITH | — |
Medicare/Medicaid MMM
S. 274- the "Medication Therapy Management Empowerment Act of 2011" -all provisions regarding amending Part D of Medicare to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management (MTM) services. HR. 891- the "Medication Therapy Management Benefits Act of 2011"- all provisions regarding amending Part D of Medicare to require that the annual comprehensive medication review, including creation of a medication record and a recommended action plan in consultation with the individual and the prescriber; requires medication therapy management (MTM) to include medication reviews person-to-person by a licensed pharmacist offered every quarter and increases the number of diseases and conditions for which beneficiaries may be targeted for MTM services. HR. 1041- the "Fairness in Medicare Bidding Act" - all provisions, regarding the repealing the Medicare Competitive Bidding acquisition program for durable medical equipment and prosthetics, orthotics and supplies (DMEPOS).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| HEATHER HERNDON SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.